Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Crovalimab in Anemia, Sickle Cell: NCT04912869 Clinical Landscape Report 2026
16 October 2026
NCT04912869 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
64Cu-LLP2A in Vaso-occlusive crisis: NCT04925492 Clinical Landscape Report 2026
16 October 2026
NCT04925492 clinical landscape for Vaso-occlusive crisis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Inclacumab in Vaso-occlusive crisis: NCT04927247 Clinical Landscape Report 2026
16 October 2026
NCT04927247 clinical landscape for Vaso-occlusive crisis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Dazucorilant in Amyotrophic Lateral Sclerosis: NL-OMON51110 Clinical Landscape Report 2026
16 October 2026
NL-OMON51110 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Inclacumab in Hematologic Diseases: PACTR202106894720601 Clinical Landscape Report 2026
16 October 2026
PACTR202106894720601 clinical landscape for Hematologic Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
WVE-004 in Frontotemporal Dementia: NCT04931862 Clinical Landscape Report 2026
16 October 2026
NCT04931862 clinical landscape for Frontotemporal Dementia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Zelasudil in Kidney Diseases: NCT04931147 Clinical Landscape Report 2026
16 October 2026
NCT04931147 clinical landscape for Kidney Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Pegozafermin in Metabolic Dysfunction Associated Steatohepatitis: NCT04929483 Clinical Landscape Report 2026
16 October 2026
NCT04929483 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
Inclacumab in Hematologic Diseases: PACTR202106511293049 Clinical Landscape Report 2026
16 October 2026
PACTR202106511293049 clinical landscape for Hematologic Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
A-4368 in Metabolic Dysfunction Associated Steatohepatitis: NCT04932252 Clinical Landscape Report 2026
16 October 2026
NCT04932252 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
IONIS-DGAT2Rx in Metabolic Dysfunction Associated Steatohepatitis: NCT04932512 Clinical Landscape Report 2026
16 October 2026
NCT04932512 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
Resmetirom in Metabolic Dysfunction Associated Steatohepatitis: NCT04951219 Clinical Landscape Report 2026
16 October 2026
NCT04951219 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…